The revenue stands at ₹3,302.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.90 per cent from ₹3,178.00 crore. This corresponds to a year-on-year *(YoY) growth of 14.30 per cent.
Operating Profit stands at ₹21.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.53 per cent from ₹19.00 crore. This corresponds to a year-on-year *(YoY) decline of 56.25 per cent.
PBDT stands at ₹404.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.32 per cent from ₹391.00 crore. This corresponds to a year-on-year *(YoY) decline of 0.49 per cent.
Profit Before Tax stands at ₹791.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.18 per cent from ₹738.00 crore. This corresponds to a year-on-year *(YoY) growth of 19.67 per cent.
Net Profit stands at ₹604.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.22 per cent from ₹548.00 crore. This represents a 33.33 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Torrent Pharma. | 0.67% | 2.16% | 4.21% | 10.26% | 16.14% | 13.96% |
| Sun Pharma.Inds. | 0.20% | 0.75% | -4.18% | 5.89% | 3.07% | -6.42% |
| Divi's Lab. | 0.49% | -0.25% | -1.26% | 8.63% | -7.19% | 5.41% |
| Cipla | 0.78% | 1.16% | 0.24% | -0.26% | 0.21% | 0.10% |
| Dr Reddy's Labs | 0.24% | -1.04% | -1.96% | 0.59% | -2.92% | -7.19% |
| Lupin | 0.09% | 1.37% | 1.32% | 6.90% | 7.79% | -10.97% |
Executive Chairman : Samir Mehta
Independent Director : Ameera Shah
Independent Director : Nayantara Bali
Managing Director : Aman Mehta
Independent Director : Manish Choksi
Company Sec. & Compli. Officer : Chintan Trivedi
Independent Director : Nikhil Khattau
Non Executive Director : Jindal Mehta